MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 21, 2004; DOI: 10.1124/mol.104.007385


0026-895X/05/6703-775-788$20.00
Mol Pharmacol 67:775-788, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.007385v1
67/3/775    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mangan, P. S.
Right arrow Articles by Kapur, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mangan, P. S.
Right arrow Articles by Kapur, J.
ORIGINAL ARTICLE

Cultured Hippocampal Pyramidal Neurons Express Two Kinds of GABAA Receptors

Patrick S. Mangan, Chengsan Sun, Mackenzie Carpenter, Howard P. Goodkin, Werner Sieghart, and Jaideep Kapur

Department of Neurology, University of Virginia, School of Medicine, Charlottesville, Virginia, (P.S.M, C.S., H.P.G., J.K.); University of Virginia, School of Medicine, Charlottesville, Virginia (M.C.); Brain Research Institute of the Medical University Vienna, Division of Biochemistry, and Molecular Biology, Vienna, Austria (W.S.)

Abstract

We combined a study of the subcellular distribution of the {alpha}1, {alpha}2, {alpha}4, {beta}1, {beta}2/3, {gamma}2, and {delta} subunits of the GABAA receptor with an electrophysiological analysis of GABAA receptor currents determine the to types of receptors expressed on cultured hippocampal pyramidal neurons. The immunocytochemistry study demonstrated that {alpha}1, {alpha}2, {beta}2/3, and {gamma}2 subunits formed distinct clusters of various sizes, which were colocalized with clusters of glutamate decarboxylase (GAD) immunoreactivity at rates ranging from 22 to 58%. In contrast, {alpha}4, {beta}1, and {delta} subunits were distributed diffusely over the cell soma and neuronal processes of cultured neurons and did not colocalize with the synaptic marker GAD. Whole-cell GABA receptor currents were moderately sensitive to GABAA and were modulated by diazepam. The whole-cell currents were also enhanced by the neurosteroid allopregnanolone (10 nM). Tonic currents, measured as changes in baseline current and noise, were sensitive to Zn2+, furosemide, and loreclezole; they were insensitive to diazepam. These studies suggest that two kinds of GABAA receptors are expressed on cultured hippocampal neurons. One kind of receptor formed clusters, which were present at GABAergic synapses and in the extrasynaptic membrane. The {alpha}1, {alpha}2, {beta}2/3, and {gamma}2 subunits were contained in clustered receptors. The second kind was distributed diffusely in the extrasynaptic membrane. The {alpha}4, {beta}1, and {delta} subunits were contained in these diffusely distributed receptors. The properties of tonic currents recorded from these neurons were similar to those from recombinant receptors containing {alpha}4, {beta}1, and {delta} subunits.


Received September 16, 2004; accepted December 21, 2004

Address correspondence to: Dr. Jaideep Kapur, Department of Neurology, Box 800394, University of Virginia-HSC, Charlottesville, VA. E-mail: jk8t{at}virginia.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
H. P. Goodkin, S. Joshi, Z. Mtchedlishvili, J. Brar, and J. Kapur
Subunit-Specific Trafficking of GABAA Receptors during Status Epilepticus
J. Neurosci., March 5, 2008; 28(10): 2527 - 2538.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. Eugene, C. Depienne, S. Baulac, M. Baulac, J. M. Fritschy, E. Le Guern, R. Miles, and J. C. Poncer
GABAA Receptor {gamma}2 Subunit Mutations Linked to Human Epileptic Syndromes Differentially Affect Phasic and Tonic Inhibition
J. Neurosci., December 19, 2007; 27(51): 14108 - 14116.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. F. Trigo, M. Chat, and A. Marty
Enhancement of GABA Release through Endogenous Activation of Axonal GABAA Receptors in Juvenile Cerebellum
J. Neurosci., November 14, 2007; 27(46): 12452 - 12463.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. R. McCartney, T. Z. Deeb, T. N. Henderson, and T. G. Hales
Tonically Active GABAA Receptors in Hippocampal Pyramidal Neurons Exhibit Constitutive GABA-Independent Gating
Mol. Pharmacol., February 1, 2007; 71(2): 539 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. H. Lagrange, E. J. Botzolakis, and R. L. Macdonald
Enhanced macroscopic desensitization shapes the response of {alpha}4 subtype-containing GABAA receptors to synaptic and extrasynaptic GABA
J. Physiol., February 1, 2007; 578(3): 655 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Mortensen and T. G. Smart
Extrasynaptic {alpha}{beta} subunit GABAA receptors on rat hippocampal pyramidal neurons
J. Physiol., December 15, 2006; 577(3): 841 - 856.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Scimemi, A. Semyanov, G. Sperk, D. M. Kullmann, and M. C. Walker
Multiple and Plastic Receptors Mediate Tonic GABAA Receptor Currents in the Hippocampus
J. Neurosci., October 26, 2005; 25(43): 10016 - 10024.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. P. Goodkin, J.-L. Yeh, and J. Kapur
Status Epilepticus Increases the Intracellular Accumulation of GABAA Receptors
J. Neurosci., June 8, 2005; 25(23): 5511 - 5520.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics